Dr. Eduardo Groisman's lab at Yale University studies how bacteria manage their proteins to survive and cause disease. They focus on the mechanisms bacteria use to control protein levels and how this affects their ability to infect hosts and resist antibiotics. Their research has important implications for understanding bacterial infections and developing new treatment strategies.

Dr. Etienne Caron's lab at Yale University focuses on uncovering how the immune system can be better harnessed to fight cancer, particularly through the analysis of tumor-specific antigens (TSAs) and self-peptides. By using advanced mass spectrometry and digital microfluidics, the lab aims to develop innovative methods for the rapid identification of key immune targets from small tissue samples, thus paving the way for personalized cancer immunotherapy. Their research challenges traditional views on T cell activation, suggesting that self-peptides play a crucial role in immune regulation.

Dr. Hualiang Pi's research lab focuses on understanding how the bacterium Clostridioides difficile adapts to iron availability in the gut and how this adaptation affects its interactions with the host and other microbes. By exploring the formation of specialized organelles called ferrosomes, which store iron and help the bacteria thrive, the lab aims to identify new ways to treat infections caused by this pathogen. The work not only addresses a critical health issue but also seeks to reveal the fundamental biological processes that govern microbial behavior in the intestine.

Dr. Jorge E. Galan's research lab at Yale University focuses on understanding how the bacterium Salmonella affects host cells. By studying the ways that Salmonella uses specific proteins to manipulate cellular functions, the lab aims to uncover the secrets of how the bacteria survive and cause disease. This research could lead to new treatments and preventions for Salmonella infections, which pose a significant public health threat. The team investigates cellular signaling pathways and immune responses to advance our knowledge of host-pathogen interactions.

Andrew L Goodman's lab at Yale University studies the complex interactions between our gut microbiome and the food we eat. They focus on how different diets influence microbial communities in our intestines and how these microbes, in turn, affect our health, specifically in relation to food-borne infections. By understanding these interactions, the lab aims to find ways to improve health outcomes and fight infections caused by pathogens like Salmonella and Campylobacter.

Dr. Joao Pereira's research lab at Yale University focuses on understanding how blood cells, particularly immune cells, develop from stem cells in the bone marrow. The lab investigates the complex signaling mechanisms that regulate the balance between cell dormancy and activity, which are crucial for maintaining a healthy immune system. Through a combination of advanced molecular techniques and imaging methods, the team's work aims to uncover new insights into immune disorders and potential therapeutic targets for diseases like cancer.

Dr. Richard Flavell's lab at Yale University focuses on studying Alcoholic Liver Disease (ALD), particularly Alcohol Associated Hepatitis (AAH), using advanced humanized mouse models. These models mimic human liver conditions better than traditional mouse models, allowing researchers to explore cellular interactions and metabolic changes in the liver that contribute to disease. The lab aims to uncover how specific signaling interactions between liver cells and immune cells are involved in AAH to identify potential treatment targets.

Dr. Ya-Chi Ho's lab at Yale University focuses on understanding how HIV-1 persists in the immune system, specifically in CD4+ T cells, which are critical for immune defense. Despite treatment, HIV-1 infected cells can survive and even proliferate, making it difficult to completely eliminate the virus. The lab uses advanced single-cell technologies to investigate the mechanisms behind HIV-1 persistence and how these infected cells evade immune responses, aiming to identify better therapeutic targets for HIV treatments.

Dr. Ruslan Medzhitov's lab at Yale University studies Immunoglobulin E (IgE), a type of antibody that plays a crucial role in the immune response. While IgE is well-known for causing allergies, the lab is interested in understanding its functions in maintaining health and fighting diseases. They aim to identify specific antigens that IgE responds to and how these interactions influence the body's response during infections and inflammation.

Dr. Nikhil Joshi's lab studies how immune cells called CD8 T cells develop and respond to tumors, particularly in lung cancer. His research focuses on the tumor-draining lymph node, where these cells are maintained, and investigates the signals that can either enhance their ability to fight tumors or lead to their dysfunction. They use advanced techniques to manipulate the immune cells genetically and analyze their behavior at the single-cell level.

Dr. Maria Lara-Tejero's lab at Yale University studies the machinery that some harmful bacteria use to infect host cells. Her team is focused on understanding how these bacteria inject proteins into host cells, which is crucial for their ability to cause disease. By using advanced imaging and genetic techniques, they seek to uncover details about this process that could help in developing new ways to combat bacterial infections.

Dr. Wenwei Li's lab at Yale University focuses on understanding how the HIV-1 virus fuses with host cells to initiate infection. They use advanced imaging techniques, particularly cryo-electron tomography, to visualize the interactions between the virus and cell membranes. The goal of this research is to uncover critical details about how HIV-1 proteins interact and change shape during the fusion process, which could lead to new treatments for HIV infection.

The lab of Dr. Jun Liu at Yale University focuses on understanding how certain bacteria, particularly Helicobacter pylori and spirochetes, manage to move and infect hosts. By studying unique structures called sheathed flagella, which help these bacteria navigate their environments, the lab aims to uncover new ways to combat infections linked to diseases like ulcers and Lyme disease. The research combines advanced imaging techniques with genetic and biochemical methods to reveal insights that could lead to new antibacterial therapies.

Dr. Carrie L. Lucas' lab at Yale University focuses on understanding how certain immune cells produce antibodies to fight infections. By studying a specific enzyme called PI3K-gamma, the lab investigates its role in B cells, the cells responsible for antibody production. The research efforts aim to uncover how defects in this pathway can lead to severe immune problems and explore potential new treatments for related diseases.

David R. Martinez's lab at Yale University is focused on developing innovative mucosal vaccines aimed at providing robust and long-lasting protection against respiratory viruses, particularly coronaviruses. The lab studies how specific adjuvants can enhance the immune response in the respiratory tract, looking to elicit protective IgA antibodies that can prevent the spread of infections. Through various experimental models, the lab aims to improve vaccination strategies to combat current and future viral threats.

Dr. Andres Hidalgo's lab focuses on understanding the diverse roles of neutrophils in the immune system, particularly how different types of neutrophils can influence inflammation, immune response, and tissue repair. Their research explores how neutrophils, which are often known for their role in fighting infections, can also be involved in processes like promoting healing and modulating the adaptive immune system. By investigating these unique functions, the lab aims to uncover new ways to harness neutrophil activity for therapeutic benefit in diseases such as cancer and chronic inflammation.

Dr. David Schatz's lab at Yale University studies how certain enzymes, specifically the RAG proteins, shape the immune system by cutting and rearranging DNA. These processes are essential for developing antibodies but can occasionally lead to mistakes that may result in blood cancers. The lab combines modern techniques in biochemistry, structural biology, and genetics to explore the intricate mechanisms of V(D)J recombination and somatic hypermutation in human cells.

Dr. Jordan S. Pober's lab at Yale University focuses on innovative approaches to improve organ transplantation and tissue engineering. By utilizing advanced techniques such as 3D printing and nanoparticle drug delivery, the lab aims to create human skin substitutes that enhance graft survival and reduce immune rejection. The research is highly relevant for developing better treatment options for patients requiring organ transplants.

Dr. Kevan C. Herold's lab at Yale University focuses on understanding and developing treatments for Type 1 diabetes, an autoimmune condition where the immune system attacks insulin-producing cells in the pancreas. The lab uses advanced pancreatic organoid models to investigate how different immune responses affect disease progression and treatment outcomes. They aim to uncover important cellular features that could lead to improved therapies and a better understanding of why some patients respond differently to treatments.